Report cover image

Global Zika Virus Testing Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Jan 01, 2026
Length 193 Pages
SKU # APRC20821984

Description

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Global Zika Virus Testing key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs, etc.

Report Includes

This report presents an overview of global market for Zika Virus Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Zika Virus Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Zika Virus Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Zika Virus Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Zika Virus Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Zika Virus Testing revenue, projected growth trends, production technology, application and end-user industry.

Zika Virus Testing Segment by Company

Chembio
Quest Diagnostics
ARUP Laboratories
Luminex
Simens
Abbott Molecular
Hologic
ELITech Molecular Diagnostics
EUROIMMUN US
Creative Diagnostics
Vela Diagnostics
InBios International
Primerdesign
Altona Diagnostics

Zika Virus Testing Segment by Type

Molecular Test
Serologic Test

Zika Virus Testing Segment by Application

Diagnostic Centers
Hospitals
Pathology Labs

Zika Virus Testing Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Zika Virus Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Zika Virus Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Zika Virus Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Zika Virus Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Zika Virus Testing Market by Type
1.2.1 Global Zika Virus Testing Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Molecular Test
1.2.3 Serologic Test
1.3 Zika Virus Testing Market by Application
1.3.1 Global Zika Virus Testing Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Pathology Labs
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Zika Virus Testing Market Dynamics
2.1 Zika Virus Testing Industry Trends
2.2 Zika Virus Testing Industry Drivers
2.3 Zika Virus Testing Industry Opportunities and Challenges
2.4 Zika Virus Testing Industry Restraints
3 Global Growth Perspective
3.1 Global Zika Virus Testing Market Perspective (2021-2032)
3.2 Global Zika Virus Testing Growth Trends by Region
3.2.1 Global Zika Virus Testing Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Zika Virus Testing Market Size by Region (2021-2026)
3.2.3 Global Zika Virus Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Zika Virus Testing Revenue by Players
4.1.1 Global Zika Virus Testing Revenue by Players (2021-2026)
4.1.2 Global Zika Virus Testing Revenue Market Share by Players (2021-2026)
4.1.3 Global Zika Virus Testing Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Zika Virus Testing Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Zika Virus Testing Key Players Headquarters & Area Served
4.4 Global Zika Virus Testing Players, Product Type & Application
4.5 Global Zika Virus Testing Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Zika Virus Testing Market CR5 and HHI
4.6.3 2025 Zika Virus Testing Tier 1, Tier 2, and Tier 3
5 Zika Virus Testing Market Size by Type
5.1 Global Zika Virus Testing Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Zika Virus Testing Revenue by Type (2021-2032)
5.3 Global Zika Virus Testing Revenue Market Share by Type (2021-2032)
6 Zika Virus Testing Market Size by Application
6.1 Global Zika Virus Testing Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Zika Virus Testing Revenue by Application (2021-2032)
6.3 Global Zika Virus Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Chembio
7.1.1 Chembio Company Information
7.1.2 Chembio Business Overview
7.1.3 Chembio Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.1.4 Chembio Zika Virus Testing Product Portfolio
7.1.5 Chembio Recent Developments
7.2 Quest Diagnostics
7.2.1 Quest Diagnostics Company Information
7.2.2 Quest Diagnostics Business Overview
7.2.3 Quest Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.2.4 Quest Diagnostics Zika Virus Testing Product Portfolio
7.2.5 Quest Diagnostics Recent Developments
7.3 ARUP Laboratories
7.3.1 ARUP Laboratories Company Information
7.3.2 ARUP Laboratories Business Overview
7.3.3 ARUP Laboratories Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.3.4 ARUP Laboratories Zika Virus Testing Product Portfolio
7.3.5 ARUP Laboratories Recent Developments
7.4 Luminex
7.4.1 Luminex Company Information
7.4.2 Luminex Business Overview
7.4.3 Luminex Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.4.4 Luminex Zika Virus Testing Product Portfolio
7.4.5 Luminex Recent Developments
7.5 Simens
7.5.1 Simens Company Information
7.5.2 Simens Business Overview
7.5.3 Simens Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.5.4 Simens Zika Virus Testing Product Portfolio
7.5.5 Simens Recent Developments
7.6 Abbott Molecular
7.6.1 Abbott Molecular Company Information
7.6.2 Abbott Molecular Business Overview
7.6.3 Abbott Molecular Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.6.4 Abbott Molecular Zika Virus Testing Product Portfolio
7.6.5 Abbott Molecular Recent Developments
7.7 Hologic
7.7.1 Hologic Company Information
7.7.2 Hologic Business Overview
7.7.3 Hologic Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.7.4 Hologic Zika Virus Testing Product Portfolio
7.7.5 Hologic Recent Developments
7.8 ELITech Molecular Diagnostics
7.8.1 ELITech Molecular Diagnostics Company Information
7.8.2 ELITech Molecular Diagnostics Business Overview
7.8.3 ELITech Molecular Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.8.4 ELITech Molecular Diagnostics Zika Virus Testing Product Portfolio
7.8.5 ELITech Molecular Diagnostics Recent Developments
7.9 EUROIMMUN US
7.9.1 EUROIMMUN US Company Information
7.9.2 EUROIMMUN US Business Overview
7.9.3 EUROIMMUN US Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.9.4 EUROIMMUN US Zika Virus Testing Product Portfolio
7.9.5 EUROIMMUN US Recent Developments
7.10 Creative Diagnostics
7.10.1 Creative Diagnostics Company Information
7.10.2 Creative Diagnostics Business Overview
7.10.3 Creative Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.10.4 Creative Diagnostics Zika Virus Testing Product Portfolio
7.10.5 Creative Diagnostics Recent Developments
7.11 Vela Diagnostics
7.11.1 Vela Diagnostics Company Information
7.11.2 Vela Diagnostics Business Overview
7.11.3 Vela Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.11.4 Vela Diagnostics Zika Virus Testing Product Portfolio
7.11.5 Vela Diagnostics Recent Developments
7.12 InBios International
7.12.1 InBios International Company Information
7.12.2 InBios International Business Overview
7.12.3 InBios International Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.12.4 InBios International Zika Virus Testing Product Portfolio
7.12.5 InBios International Recent Developments
7.13 Primerdesign
7.13.1 Primerdesign Company Information
7.13.2 Primerdesign Business Overview
7.13.3 Primerdesign Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.13.4 Primerdesign Zika Virus Testing Product Portfolio
7.13.5 Primerdesign Recent Developments
7.14 Altona Diagnostics
7.14.1 Altona Diagnostics Company Information
7.14.2 Altona Diagnostics Business Overview
7.14.3 Altona Diagnostics Zika Virus Testing Revenue and Gross Margin (2021-2026)
7.14.4 Altona Diagnostics Zika Virus Testing Product Portfolio
7.14.5 Altona Diagnostics Recent Developments
8 North America
8.1 North America Zika Virus Testing Revenue (2021-2032)
8.2 North America Zika Virus Testing Revenue by Type (2021-2032)
8.2.1 North America Zika Virus Testing Revenue by Type (2021-2026)
8.2.2 North America Zika Virus Testing Revenue by Type (2027-2032)
8.3 North America Zika Virus Testing Revenue Share by Type (2021-2032)
8.4 North America Zika Virus Testing Revenue by Application (2021-2032)
8.4.1 North America Zika Virus Testing Revenue by Application (2021-2026)
8.4.2 North America Zika Virus Testing Revenue by Application (2027-2032)
8.5 North America Zika Virus Testing Revenue Share by Application (2021-2032)
8.6 North America Zika Virus Testing Revenue by Country
8.6.1 North America Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Zika Virus Testing Revenue by Country (2021-2026)
8.6.3 North America Zika Virus Testing Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Zika Virus Testing Revenue (2021-2032)
9.2 Europe Zika Virus Testing Revenue by Type (2021-2032)
9.2.1 Europe Zika Virus Testing Revenue by Type (2021-2026)
9.2.2 Europe Zika Virus Testing Revenue by Type (2027-2032)
9.3 Europe Zika Virus Testing Revenue Share by Type (2021-2032)
9.4 Europe Zika Virus Testing Revenue by Application (2021-2032)
9.4.1 Europe Zika Virus Testing Revenue by Application (2021-2026)
9.4.2 Europe Zika Virus Testing Revenue by Application (2027-2032)
9.5 Europe Zika Virus Testing Revenue Share by Application (2021-2032)
9.6 Europe Zika Virus Testing Revenue by Country
9.6.1 Europe Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Zika Virus Testing Revenue by Country (2021-2026)
9.6.3 Europe Zika Virus Testing Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Zika Virus Testing Revenue (2021-2032)
10.2 China Zika Virus Testing Revenue by Type (2021-2032)
10.2.1 China Zika Virus Testing Revenue by Type (2021-2026)
10.2.2 China Zika Virus Testing Revenue by Type (2027-2032)
10.3 China Zika Virus Testing Revenue Share by Type (2021-2032)
10.4 China Zika Virus Testing Revenue by Application (2021-2032)
10.4.1 China Zika Virus Testing Revenue by Application (2021-2026)
10.4.2 China Zika Virus Testing Revenue by Application (2027-2032)
10.5 China Zika Virus Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Zika Virus Testing Revenue (2021-2032)
11.2 Asia Zika Virus Testing Revenue by Type (2021-2032)
11.2.1 Asia Zika Virus Testing Revenue by Type (2021-2026)
11.2.2 Asia Zika Virus Testing Revenue by Type (2027-2032)
11.3 Asia Zika Virus Testing Revenue Share by Type (2021-2032)
11.4 Asia Zika Virus Testing Revenue by Application (2021-2032)
11.4.1 Asia Zika Virus Testing Revenue by Application (2021-2026)
11.4.2 Asia Zika Virus Testing Revenue by Application (2027-2032)
11.5 Asia Zika Virus Testing Revenue Share by Application (2021-2032)
11.6 Asia Zika Virus Testing Revenue by Country
11.6.1 Asia Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Zika Virus Testing Revenue by Country (2021-2026)
11.6.3 Asia Zika Virus Testing Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Zika Virus Testing Revenue (2021-2032)
12.2 SAMEA Zika Virus Testing Revenue by Type (2021-2032)
12.2.1 SAMEA Zika Virus Testing Revenue by Type (2021-2026)
12.2.2 SAMEA Zika Virus Testing Revenue by Type (2027-2032)
12.3 SAMEA Zika Virus Testing Revenue Share by Type (2021-2032)
12.4 SAMEA Zika Virus Testing Revenue by Application (2021-2032)
12.4.1 SAMEA Zika Virus Testing Revenue by Application (2021-2026)
12.4.2 SAMEA Zika Virus Testing Revenue by Application (2027-2032)
12.5 SAMEA Zika Virus Testing Revenue Share by Application (2021-2032)
12.6 SAMEA Zika Virus Testing Revenue by Country
12.6.1 SAMEA Zika Virus Testing Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Zika Virus Testing Revenue by Country (2021-2026)
12.6.3 SAMEA Zika Virus Testing Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.